ANTI-CD28 IMMUNOTHERAPY IN MURINE VISCERAL LEISHMANIASIS

被引：0
|
作者：
KAYE, PM
GORAK, P
MURPHY, M
PERRIN, PJ
JUNE, CH
机构：
[1] UNIV LONDON LONDON SCH HYG & TROP MED,DEPT MED PARASITOL,LONDON WC1E 7HT,ENGLAND
[2] USN,MED RES INST,IMMUNE CELL BIOL PROGRAM,BETHESDA,MD 20889
来源：
JOURNAL OF CELLULAR BIOCHEMISTRY | 1995年
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：171 / 171
页数：1
相关论文
共 50 条
  • [1] REVISITING ANTI-CD28 THERAPY
    Vanhove, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 5 - 5
  • [2] T cells coactivated with immobilized anti-CD3 and anti-CD28 as potential immunotherapy for cancer
    Garlie, NK
    LeFever, AV
    Siebenlist, RE
    Levine, BL
    June, CH
    Lum, LG
    JOURNAL OF IMMUNOTHERAPY, 1999, 22 (04): : 336 - 345
  • [3] The impact of CD28 blockade by anti-CD28 antibody on the intimal proliferation in a murine aorta transplantation model.
    Higashi, Y
    Warnecke, G
    Chapman, S
    Bushell, A
    Masunaga, T
    Tamura, K
    Wood, KJ
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 556 - 556
  • [4] Cytokine storm and an anti-CD28 monoclonal antibody
    Corry, David B.
    Lewis, Dorothy E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (24) : 2592 - 2592
  • [5] ANTI-CD28 THERAPEUTICS FOR THE TREATMENT OF AUTOIMMUNE DISORDERS
    Poirier, N.
    Vanhove, B.
    DRUGS OF THE FUTURE, 2016, 41 (04) : 229 - 235
  • [6] Immunotherapy with leishmanial antigen versus immunochemotherapy in murine visceral leishmaniasis
    Afrin, Farhat
    Chouhan, Garima
    Islamuddin, Mohammad
    Priya, Yadav
    Ahmad, Farnaz
    Want, Muzamil
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [7] Developing safe and effective immunotherapy: Lessons from anti-CD28 trails (TGN1412)
    Duff, Gordon
    CYTOKINE, 2009, 48 (1-2) : 31 - 31
  • [8] Immunotherapy against murine experimental visceral leishmaniasis with the FML-vaccine
    Santos, WR
    Aguiar, IA
    de Souza, EP
    de Lima, VMF
    Palatnik, M
    Palatnik-de-Sousa, CB
    VACCINE, 2003, 21 (32) : 4668 - 4676
  • [9] Specific immunotherapy with tumour-draining lymph node cells cultured with both anti-CD3 and anti-CD28 monoclonal antibodies
    Harada, M
    Okamoto, T
    Omoto, K
    Tamada, K
    Takenoyama, M
    Hirashima, C
    Ito, O
    Kimura, G
    Nomoto, K
    IMMUNOLOGY, 1996, 87 (03) : 447 - 453
  • [10] COACTIVATION OF CD3+, CD4+, AND CD8+ CELLS WITH ANTI-CD3 + ANTI-CD28 INDUCES GROWTH AND CYTOTOXICITY FOR ADOPTIVE IMMUNOTHERAPY
    LUM, LG
    JOSHI, ID
    JUNE, C
    MARTILOTTI, F
    GALOFORO, S
    UBERTI, JP
    LEDBETTER, JA
    SENSENBRENNER, LL
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 729 - 729
12345